newsfilter
← Latest News
GlobeNewswire·

Vigil Neuroscience to Present at the Stifel 2025 Virtual CNS Forum

WATERTOWN, Mass., March 11, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative